SYNAGILE
SynAgileâ„¢ is dedicated to transforming the treatment of L-DOPA-responsive motor and non-motor complications in patients with Parkinson's disease. Our novel drugs and routes of administration are designed to enable patients to achieve stable plasma L-DOPA concentrations, and to provide convenient, continuous dopaminergic stimulation.
SYNAGILE
Social Links:
Industry:
Biotechnology Health Care Health Diagnostics
Founded:
2011-01-01
Address:
Piedmont, California, United States
Country:
United States
Website Url:
http://www.synagile.com
Total Employee:
1+
Status:
Active
Contact:
510-908-3496
Email Addresses:
[email protected]
Total Funding:
11.3 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Amazon Google Apps For Business GoDaddy DNS AWS Global Accelerator OpenResty GoDaddy SSL
Similar Organizations
Lucira Health
Lucira Health is a biotechnology company that offers disposable test kits to detect RNA and DNA of infectious diseases.
Homology Medicines
Homology Medicines is a genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases.
Idenix Pharmaceuticals
Idenix Pharmaceuticals is focused on the discovery and development of drugs for the treatment of human viral diseases.
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Radius Health
Radius Health develops drug therapies for osteoporosis and women’s health.
Current Employees Featured
Founder
Official Site Inspections
http://www.synagile.com
- Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
- IP address: 15.197.148.33
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "SynAgile"
SynAgile - Crunchbase Company Profile & Funding
SynAgileâ„¢ is dedicated to transforming the treatment of L-DOPA-responsive motor and non-motor complications in patients with Parkinson's disease. Our novel drugs and routes of administration are designed to enable patients to …See details»
SynAgile Company Profile 2024: Valuation, Funding
SynAgile General Information Description. Developer of a non-invasive drug delivery system designed to perform continuous delivery of levodopa and carbidopa in patients suffering from Parkinson's disease. The company's …See details»
Synagile Corporation Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Synagile Corporation of Brookline, MA. Get the latest business insights from Dun & Bradstreet.See details»
SynAgile Corp - Company Profile and News - Bloomberg Markets
Company profile page for SynAgile Corp including stock price, company news, executives, board members, and contact informationSee details»
Synagile Company Profile - Office Locations, Competitors ... - Craft
Synagile is a company developing DopaFuse, non-invasive therapy for the continuous delivery of levodopa and carbidopa. It is designed for Parkinson's disease patients and provides more …See details»
SynAgile - Overview, News & Similar companies | ZoomInfo.com
Oct 26, 2021 SynAgile Corporation Announces Positive Phase 2 Top Line Results for DopaFuse® Levodopa-Carbidopa Delivery System SAN JOSE, Calif., Nov. 04, 2022 (GLOBE …See details»
SynAgile - Contacts, Employees, Board Members, Advisors & Alumni
SynAgile offers DopaFuse, an infusion therapy to stabilize L-DOPA levels in the body for patients who suffer from Parkinson’s disease. ... Solutions. Products. Resources. Pricing. Resources. …See details»
SynAgile - Products, Competitors, Financials, Employees, …
SynAgile is a medical devices company focused on the development of non-invasive therapies for continuous drug delivery, particularly in the field of Parkinson's Disease. The company's main …See details»
SynAgile Completes Enrollment of its Phase 2 Clinical Trial of its ...
Sep 1, 2022 SynAgile is a pharmaceutical company focused on developing and commercializing therapeutics using its proprietary OraFuse® noninvasive, continuous, oral dosing technology, …See details»
SynAgile - Funding, Financials, Valuation & Investors - Crunchbase
Organization. SynAgile . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Funding Rounds 2. Total Funding Amount …See details»
SynAgile Corporation Announces Closing of Financing, …
Sep 22, 2021 SynAgile is a pharmaceutical company focused on developing and commercializing therapeutics using its proprietary OraFuse ® noninvasive, continuous, oral …See details»
SynAgile takes on debt to wrap up midphase trial of drug delivery ...
Sep 28, 2021 SynAgile began a phase 2 clinical trial of the device, OraFuse, earlier this year. ... Olanow is CEO of Clintrex, a clinical research organization collaborating with SynAgile on the …See details»
SynAgile Corporation Announces Positive Phase 2 Top Line Results …
SAN JOSE, Calif., Nov. 04, 2022 (GLOBE NEWSWIRE) -- SynAgile Corporation (www.SynAgile.com) today announced positive results from its Phase 2 clinical trial of …See details»
SynAgile Completes Enrollment of its Phase 2 Clinical Trial
Sep 1, 2022 SynAgile is a pharmaceutical company focused on developing and commercializing therapeutics using its proprietary OraFuse® noninvasive, continuous, oral dosing technology, …See details»
SynAgile Corporation Announces Positive Phase 2a Results for …
Oct 8, 2015 SynAgile is a biopharmaceutical company focused on developing and commercializing transformative therapeutics using its proprietary OraFuseâ„¢ intraoral …See details»
SynAgile Corporation Announces Positive Phase 2 Top Line
Nov 4, 2022 SynAgile is a privately-held startup company developing the OraFuse drug delivery platform for the administration of drugs where continuous oral delivery could be advantageous.See details»
First Patient Treated with the DopaFuse® Delivery System - Yahoo …
Oct 27, 2021 SynAgile was founded by highly successful serial inventor-entrepreneurs Adam Heller (CSO) and Ephraim Heller (CEO). The father-son team have over 300 patents and a …See details»
In Parkinson's Trial, DopaFuse Safely Delivers Levodopa-carbidopa...
Nov 8, 2022 According to SynAgile, patients reportedly were highly satisfied with the DopaFuse system. “SynAgile is now scaling up manufacturing at its facility in San Jose, CA, in …See details»
SynAgile - Tech Stack, Apps, Patents & Trademarks - Crunchbase
SynAgile uses 9 technology products and services including HTML5, Apache Server, and Google Analytics, according to G2 Stack. SynAgile is actively using 15 technologies for its website, …See details»
The five trademarks of agile organizations | McKinsey
Jan 22, 2018 When pressure is applied, the agile organization reacts by being more than just robust; performance actually improves as more pressure is exerted. 4 Research shows that …See details»